Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

Hematologic Changes and Factors Related to Postoperative Hemorrhage Following Cardiopulmonary Bypass

체외순환에 따른 혈액학적 변화와 술후 출혈에 관계하는 인자에 관한 연구

  • 김하늘루 (인제대학교 의과대학 부산 백병원 흉부외과학교실) ;
  • 황윤호 (인제대학교 의과대학 부산 백병원 흉부외과학교실) ;
  • 최석철 (인제대학교 의과대학 부산 백병원 흉부외과 체외순환 연구실) ;
  • 최국렬 (인제대학교 통계학과) ;
  • 김승우 (인제대학교 의과대학 부산 백병원 흉부외과학교실) ;
  • 조광현 (인제대학교 의과대학 부산 백병원 흉부외과학교실)
  • Published : 1998.10.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Cardiopulmonary bypass(CPB)-induced hemostatic defects may result increased possibility of excessive hemorrhage and additional multiple transfusion reactions or reoperation. Particularly, fibrinolytic activation and decreased platelet count and function by CPB were proposed as a predictor of hemorrhage during postoperative periods in several reports. Materials and methods: Present study, which was conducted in 20 adult patients undergoing CPB, was prospectively designed to examine the hematologic changes, including fibrinolytic activation during and after CPB and to clarify the relationships between these changes and the magnitude of the postoperative nonsurgical blood loss. The serial blood samples for measurment of hematologic parameters were taken during operation and postoperative periods. Blood loss was respectively counted via thoracic catheter drainage at postoperative 3, 6, 12, 24, 48 hours and total period. Results: The results were obtained as follows:Platelet count rapidly declined following CPB(p<0.01), which its decreasing rate was an inverse proportion to total bypass time(TBT, r=0.55, p=0.01), And platelet count in postoperative 7th day was barely near to its control value. Fibrinogen degradating product(FDP) and D-dimer level significantly increased during CPB(p<0.0001, p<0.0001, respectively), and both of fibrinogen and plasminogen concentration correlatively decreased during CPB(r=0.57, p<0.01), implying activation of fibrinolytic system. Postoperative bleeding time (BT), postoperative activated partial thromboplastin time(aPTT) and postoperative prothrombin time (PT) were significantly prolonged as compare with each control value (p=0.05, p<0.0001, p<0.0001, respectively). Total blood loss was positively correlated with patient's age, aortic clamping time (ACT) and TBT, while there was negative correlation between platelet count and blood loss at pre-CPB, CPB-off and the 1st postoperative day, and in some periods. Postoperative aPTT and postoperative PTwere positively related to postoperative 6 hr and 48 hr blood loss(r=0.53, p=0.02; r=0.43, p=0.05) but not to total blood loss, whereas there was no relationship between postoperative BT and blood loss at any period. Conclusions: These observations suggest that CPB results various hematologic changes, including fibrinolytic activation and severe reduction in platelet count. Diverse factors such as age, platelet count, ACT, TBT and postoperative aPTT and PT may magnify the postoperative bleeding. This study will be a basic reference in understanding CPB-induced hemostatic injuries and in decreasing the postoperative hemorrhage

연구배경 : 체외 순환으로 인한 지혈 기전의 심각한 손상은 술후 과다 출혈을 일으켜 환자의 생명을 위협하고, 대량 수혈에 따른 부작용과 재수술의 우려마저 증가시킬 수 있다. 특히, 심장 수술동안 섬유소 용해계의 활성화와 혈소판의 숫적, 기능적 변화가 술후 상당 시간동안 출혈의 원인이 된다고 보고하고 있다 대상 및 방법 : 본 연구는 체외 순환 동안 및 그 후에 있어, 체외 순환에 의한 섬유소 용해계의 활성화를 포함한 다양한 혈액학적 변화를 조사하고, 이러한 변화들이 술후 비외과적 출혈의 정도와 어떤 상관성이 있는가를 규명하기위해 체외 순환을 실시할 성인 환자 20명을 대상으로 전향적으로 계획되었다. 혈소판 수, 섬유소원 및 plasminogen 농도, FDP, D-dimer, BT, aPTT, PT와 같은 혈액학적 변수의 측정을 위해 수술동안 또는 술후 시기에 혈액을 연속적으로 채취하였다. 출혈량은 흉부 삽관을 통한 배출량을 술후 3, 6, 12, 24, 48시간의 양과 총혈액량을 각각 측정하였다. 결과 : 연구 결과를 요약하면 다음과 같다:혈소판 수는 체외 순환으로 인해 급격히 감소되었다 (p<0.01). 총 체외 순환 시간이 길수록 혈소판 수의 감소률은 더 높았으며 (r=0.55, p=0.01) 술후 7일이 되어서야 비로소 술전치에 근접하였다. 체외 순환동안 FDP와 D-dimer의 농도가 의미있게 증가하였고 (p<0.0001), 섬유소원 및 plasminogen 농도 둘 다 서로간에 상관성을 보이면서 감소하였다 (r=0.57, p<0.01). 술후 2hr-BT, 2hr-PT, 2hr-aPTT 모두 술전치에 비해 유의하게 연장되었다(각각 p<0.05, p<0.0001, p<0.0001). 술후 총 출혈량과 환자의 연령, 대동맥 차단 시간, 체외 순환 시간은 각각 양의 상관관계 (positive correlation)가 있었다. 술전 기준치 혈소판 수와 술후 3시간 출혈량, 체외 순환 종료시의 혈소판 수와 술후 3시간, 6시간 및 총 출혈량 그리고 술후 1일의 혈소판 수와 48시간 출혈량 사이에는 각각 음의 상관관계 (negative correlation)가 있었다. 술후 2hr-aPTT는 술후 6시간 및 48시간대의 출혈량에 상관성이 있었고 (r=0.53, p=0.02) 술후 2hr-PT는 48시간 출혈량과 각각 양의 상관성이 있었으나 (r=0.43, p=0.05). 이 두가지 변수와 총 출혈량 간에는 상관성이 없었고, 술후 2hr-BT와 술후 출혈량 사이에도 유의한 상관성을 발견하지 못하였다. 결론 : 이상의 관찰 결과들은 체외 순환이 섬유소 용해계의 활성화와 혈소판 수의 심한 감소를 포함한 다양한 혈액학적 변화를 유도하고 환자의 연령, 혈소판 수, 대동맥 차단 시간, 체외 순환 시간, 술후 PT 및 aPTT와 같은 다인적 상황들이 술후 출혈에 영향을 미친다는 점들을 시사하고 있다. 본 연구 결과들은 체외 순환에 따른 지혈적 손상에 관한 이해와 술후 출혈을 감소시키기 위한 기초 자료로 활용 가능하리라 사료된다.

Keywords

References

  1. 최신의학 v.38 심장 수술이 혈소판 수와 술후 출혈에 미치는 영향에 관한 연구 최석철
  2. Blood v.56 Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective alphagranule release Harker LA;Malpass TW;Branson HE(et al.)
  3. Thromb Haemost v.59 Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients Holloway DS;Summaria L;Sandesara J(et al.)
  4. Sem Thromb Hemostas v.11 Hemosstasis changes during cardiopulmonary surgery Mammen EF;Koots MH;Washington BC(et al.)
  5. Thromb Res v.7 Studies of fibrinolytic and coagulation factors during open heart surgery:Ⅲ. Postoperative bleeding tendency and changes in the coagulation system Muller N;Popov-Cenic S;Buttner W(et al.)
  6. J Cardiothorac Anaesth v.3 Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery Tanaka K;Takao M;Yada I(et al.)
  7. J Thorac Cardiovasc Surg v.104 Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss Khuri SF;Wolfe JA;Josa M(et al.)
  8. J Thorac Cardiovasc Surg v.94 The protein C system in Patients undergoing cardiopulmonary bypass Knobl P;Zilla P;Fasol R(et al.)
  9. Am J Clin Pathol v.87 Heparin-protamine complexes in the production of heparin rebound and other complications of extracorporeal bypass procedures Shanberge JN;Murato M;Quattrociocchi(et al.)
  10. Ann Thorac Surg v.42 Platelet damaged by protamine and the protective effect of prostacyclin: An experimental study in dogs Velders AJ;Wildevuur RH
  11. J Thora Cardiovasc Surg v.77 Cardiopulmonary bypass:associated hemostatic abnormalities Kalter RD;Saul CM;Wetstein L(et al.)
  12. J Thorac Cardiovasc Surg v.111 Reexploration for adverse outcomes after cardiac operations Moulton MJ;Creswell LL;Mackey ME(et al.)
  13. N Engl J Med v.303 Heparin-associated thrombocytopenia Cines DB;Kaywin P;Bina M(et al.)
  14. J Cardiothorac Anesth v.5 The contribution of platelet dysfunction to postbypass bleeding Campbell FW
  15. J Thorac Cardiovasc Surg v.81 Kinetics and sites of sequestration of indium 111-labeled human platelets during cardiopulmonary bypass Hope AF;Heyns AD;Loter MG(et al.)
  16. 대흉외지 v.21 체외 순환이 혈소판에 미치는 영향 최준영;서경필
  17. 대흉외지 v.2 개심술시 체외 순환이 혈소판에 미치는 영향 최재융;신현중;최세영(등)
  18. 대흉외지 v.25 체외 순환에 따른 혈소판 수의 변화에 관한 임상적 연구 김영진;고영로;김용한(등)
  19. Thromb Haemost v.68 Early activation of hemostasis during cardiopulmonary bypass evidence for thrombin mediated hyperfibrinolysis Teufelsbauer H;Proidl S;Havel M(et al.)
  20. Surgery v.78 Periepicardial fibrinolytic activity: Relation to cardiac bleeding Rhodes GR;Siver D
  21. Ann Thorac Surg v.60 Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass Khuri SF;Valeri CR;Loscalzo J(et al.)
  22. J Thorac Cardiovasc Surg v.46 Hemorrhage due to fibrinolysis occurring with open-heart operations Tice DA;Reed GE;Class RH;Worth MH
  23. Thromb Haemost v.74 Individual variations in the fibrinolytic response during and cardiopulmonary bypass Chandler WL;Fitch JCK;Wall MH(et al.)
  24. Blood Coag Fibrinol v.5 Relationship of fibrionlysis and platelet function to bleeding after cardiopulmonary bypass Ray MJ;Marsh NA;Hawson GAT
  25. Circulation v.85 In vitro effect of plasmin on human platelet function in plasmn. Inhibition of aggregation caused by fibrinolysis Gouin I;Lecompet T;Moteln MC(et al.)
  26. Blood v.65 Plasmin effecr on platelet glycoprotein Ib-von Willebrand factor interaction Adelman B;Michelson AD;Loscalzo J(et al.)
  27. J Thorac Cardiovasc Surg v.97 Loss of platelet fibrinogen receptors during clinical cardioulmonary bypass Wenger RK;Lukasiewicz H;Mikuta BS(et al.)
  28. J Thorac Cardiovasc Surg v.61 The hemostatic response to open heart operations Gralnick HR;Fischer RD
  29. Scand J Thorac Cardiovasc Surg v.20 Coagulation, fibrinolysis and bleeding after open-heart surgery Bagge L;Lilienberg G;Nystrom SO;Tyden H
  30. Am J Clin Pathol v.76 Alteration of coagulation and selected clinical chemistry parameters in patients undergoing open heart surgery without transfusions Milam JD;Austin SF;Martin RF(et al.)
  31. Thromb Res v.8 Alterations of hemostasis associated with cardiopulmonary bypass Bick RL;Schmalhorst WR;Arbegast NR
  32. J Thorac Cardiovasc Surg v.70 The hemostatic mechanism after extracorporeal circulation Backmann F;Mckenna R;Cole ER;Najafi
  33. Circulatory Shock v.32 Hypothermia and blood coagulation: Dissociation between enzyme activity and clotting factor levels Reed RL;Bracey AW;Hudson JD(et al.)
  34. Lancet v.1 Fibrinolysis and bleeding in open heart surgery Bental HH;Allwork SP
  35. Effective hemostasis in cardiac surgery Fibrinolysis: A frequent cause of bleeding Marengo-Rowe AJ;Levenson JE;Ellison N(ed.);Jobes DR(ed.)
  36. J Clin Monit v.3 Thromboelastography as an indicator of postcardiopulmonary bypass coagulopathies Spiess BD;Tuman KJ;McCarthy RJ(et al.)